AVIR Net Income Growth
-21.42%TTM
Period ending:
AVIR TTM Net Income YoY %%
1445.95%-1022.56%
2020-12-312026-06-30
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
AVIR net income growth history
Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 23 observations from Dec 31, 2020 to Jun 30, 2026.
| Period ending | Net Income Growth |
|---|---|
| -21.4226% | |
| -21.528% | |
| 5.9602% | |
| 15.5058% | |
| 22.6538% | |
| 14.7686% | |
| -23.8526% | |
| -32.6033% | |
| -65.805% | |
| -49.7342% | |
| -17.2955% | |
| -468.0457% | |
| -783.6725% | |
| -325.8244% | |
| -195.6424% | |
| 44.2664% | |
| -55.9995% | |
| 103.7552% | |
| 1,207.0613% | |
| 168.1615% | |
| 258.4606% | |
| 250.0663% | |
| 21.9966% |
Compare net income growth
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Brightspring Health Services Inc (BTSG) net income growth
- Ensign Group Inc (ENSG) net income growth
- Krystal Biotech Inc (KRYS) net income growth
- Protagonist Therapeutics Inc (PTGX) net income growth
- Tg Therapeutics Inc (TGTX) net income growth
- Healthequity Inc (HQY) net income growth
- Pacs Group Inc (PACS) net income growth
- Alkermes (ALKS) net income growth
Compare all covered stocks by net income growth →
All AVIR financial metrics · AVIR stock overview · How to interpret financial metrics
